Autoimmune pancreatitis is one of the human autoimmune diseases. Autoimmune pancreatitis was only recently discovered (previously often confused with other conditions), a finding that now plays an important role in making treatment more effective.

Autoimmune pancreatitis is one of the human autoimmune diseases. Autoimmune pancreatitis was only recently discovered (previously often confused with other conditions), a finding that now plays an important role in making treatment more effective.

Autoimmune pancreatitis is one of the human autoimmune diseases. The disease has only been discovered recently (previously often confused with other diseases), this finding has played an important role in making treatment more effective.

Th2 cells, Tregs cells, Tfh cells, and CD4+ CTLs cells were detected in the peripheral blood of patients with autoimmune pancreatitis or IgG4-RD and markedly decreased after remission. This raises the possibility that serum levels of effector T cells-derived immune cytokines could be useful biomarkers.

Exocrine pancreatic insufficiency (EPI) is a condition that occurs when your pancreas cannot produce or secrete enough digestive enzymes to break down food and absorb nutrients. Because there are no exact symptoms, it is difficult to detect in the early stages of the disease.

Autoimmune pancreatitis is an uncommon cause of chronic and recurrent pancreatitis. It occurs as a primary autoimmune process of the pancreas or as a secondary component of a systemic autoimmune disorder.

Single organ autoimmune disorders, previously known as autoimmune pancreatitis (AIP), autoimmune cholangitis, and autoimmune sclerosing cholangitis, are now considered organ-specific manifestations of systemic immunoglobulin G4-related disease (IgG4-RD). Autoimmune pancreatitis and IgG4-RD are characterized by elevated serum IgG4 antibody (Ab) levels, accumulation of IgG4-expressing plasmacytes in affected organs, and multiorgan involvement.

Autoimmune pancreatitis and immunoglobulin G4-related disease (IgG4-RD) are new disease entities characterized by enhanced IgG4 antibody responses. Serum IgG4 antibody concentrations are widely used as useful biomarkers for the diagnosis and monitoring of disease activity in autoimmune pancreatitis and IgG4-RD.